We have assessed the effect of anti-IL-5-mAb in asthmatic patients with and without nasal polyps, Bajpai et al. [7] in asthmatic patients with CRS, while the SYNAPSE and OSTRO studies focused on CRSwNP patients exclusively. The gene discussed is IL5; the disease is chronic rhinosinusitis with nasal polyps.